Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erythrocytosis-inducing PHD2 mutations implicate biological role for N-terminal prolyl-hydroxylation in HIF1α oxygen-dependent degradation domain. | Elife | 2025 | 41114716 | PubTator, text mining | PubMed |
| Light-driven biosensor for the rapid and selective detection of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors in aqueous media and saliva. | Mikrochim Acta | 2025 | 41034642 | PubTator, text mining | PubMed |
| Exploring the genetic footprints of high altitude adapted humans and livestock. | Mamm Genome | 2025 | 41028289 | PubTator, text mining | PubMed |
| Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α. | Leukemia | 2025 | 40897850 | PubTator, text mining | PubMed |
| DNA methylation in adaptation to high-altitude environments and pathogenesis of related diseases. | Hum Genomics | 2025 | 40886024 | PubTator, text mining | PubMed |
| Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | 40884151 | PubTator, text mining | PubMed |
| Size-dependent temporal decoupling of morphogenesis and transcriptional programs in pseudoembryos. | Sci Adv | 2025 | 40845108 | PubTator, text mining | PubMed |
| Prakriti elucidates the inter-individual variability in coronary artery disease risk-predicting biomarkers: A tertiary care hospital-based case control study. | J Ayurveda Integr Med | 2025 | 40829435 | PubTator, text mining | PubMed |
| Large language model powered knowledge graph construction for mental health exploration. | Nat Commun | 2025 | 40804250 | PubTator, text mining | PubMed |
| Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target? | Virulence | 2025 | 40802588 | PubTator, text mining | PubMed |
| A schema for sporadic and heritable disease pathogenesis integrating spatiotemporal distribution with the character of genetic variants. | Commun Med (Lond) | 2025 | 40781556 | PubTator, text mining | PubMed |
| Metastatic Pheochromocytoma in a Patient With Li-Fraumeni Syndrome. | JCEM Case Rep | 2025 | 40757052 | PubTator, text mining | PubMed |
| Exploring the prognostic value and immune landscape of EGLN1 in colorectal cancer: insights from bioinformatics analysis. | Discov Oncol | 2025 | 40753313 | PubTator, text mining | PubMed |
| What should we focus on in pregnancy complicated by pheochromocytoma? a bibliometric analysis (1990-2024). | Front Oncol | 2025 | 40746609 | PubTator, text mining | PubMed |
| A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis. | Br J Haematol | 2025 | 40685776 | PubTator, text mining | PubMed |
| Dysregulation of metabolites and high-altitude illnesses development under plateau conditions. | Front Physiol | 2025 | 40671709 | PubTator, text mining | PubMed |
| Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia. | Ann Hematol | 2025 | 40670727 | PubTator, text mining | PubMed |
| Advances in Understanding Adaptive Hemoglobin Concentration at High Altitude. | Am J Hum Biol | 2025 | 40650341 | PubTator, text mining | PubMed |
| EGLN1-positive familial erythrocytosis: a rare variant with an unusually aggressive clinical course. | J Hematop | 2025 | 40627222 | PubTator, text mining | PubMed |
| Development and validation of a prognostic model for efferocytosis-associated genes in cervical squamous cell carcinoma. | Discov Oncol | 2025 | 40591190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=6